Nav: Home

Early weight loss in Parkinson's disease patients may signify more serious form of disease

January 11, 2016

A study led by a Massachusetts General Hospital (MGH) investigator finds evidence of an association between weight loss in patients with early Parkinson disease and more rapid disease progression. While weight loss is common in Parkinson's patients, results of the study - which is being released online prior to publication in the March issue of JAMA Neurology - could suggest that weight loss early in the course of the disease signifies a more serious form of the neurodegenerative disorder.

"I suspect we may be looking at several subtypes of this disease," says Anne-Marie Wills, MD, of the MGH Department of Neurology and Neurological Clinical Research Institute, lead and corresponding author of the JAMA Neurology paper. "The patients who experience early weight loss appear to have a more severe, systemic form of the disease, possible due to involvement of the neuroendocrine system or the gastrointestinal nervous system, while those who gained weight may have a milder form of the disease."

While previous studies have found that a higher body mass index (BMI) - a measure of weight relative to height - is associated with improved survival in Huntington disease and amyotrophic lateral sclerosis (ALS), no published study has examined the relationship of weight to disease progression and survival in Parkinson disease. Wills and her co-authors from eight other U.S. research centers examined data collected in conjunction with an NIH-sponsored clinical trial conducted from 2007 until 2013 to investigate the use of creatine to treat early-stage disease. That trial enrolled more than 1,700 patients who were within five years of diagnosis and from 90 days to two years after beginning treatment with dopamine-releasing drugs and was stopped early when creatine treatment was found to have no benefit.

Data required for the current study - including annual height and weight measurement and results from the Unified Parkinson's Disease Rating Scale (UPDRS) covering the three to five years of trial enrollment - was available for 1,673 study participants. For 77 percent of the participants (1,282), BMI remained stable during the study period; 158 participants (9 percent) experienced weight loss, and 233 (14 percent) actually gained weight. Those who lost weight during the study period showed a greater average increase in UPDRS score - indicating a worsening of symptoms - both in terms of motor symptoms and overall than did those whose weight remained stable. Participants who gained weight had the smallest annual increase in UPDRS scores. There was no significant difference in survival among the three groups, but that may reflect the fact that participants were in the early stages of their disease.

The authors note that it is not currently possible to determine whether maintaining or even increasing weight might help slow disease progression, although this hypothesis was supported by a 2014 interventional study in ALS also led by Wills. "Since this is just the first observation of this association in Parkinson's, we cannot recommend any changes to standard clinical care right now," she says. "But in my own practice, I try to prevent weight loss in patients, and I would recommend providers to be attentive to weight changes in their patients, even early in the disease." Wills is an assistant professor of Neurology at Harvard Medical School.
Co-authors of the JAMA Neurology paper are Adriana Pérez, PhD, and Suja Rajan, PhD, University of Texas Health Science Center at Houston; Jue Wang, MS, and Xiao Su, University of Texas School of Public Health; John Morgan, MD, Medical College of Georgia; Maureen Leehey, MD, University of Colorado School of Medicine; Gregory Pontone, MD, and Zoltan Mari, MD, Johns Hopkins University; Kelvin Chou, MD, University of Michigan; Chizoba Umeh, MD, Brigham and Women's Hospital; and James Boyd, MD, University of Vermont College of Medicine.

Support for the study includes National Institute for Neurological Disorders and Stoke grants U01 NS043127, U01 NS043128, and U10 NS44415-44555 and by grants 8 UL1 TR000170-05 and UL1 RR025758-04 from the National Center for Advancing Translational Science and the National Center for Research Resources to the Harvard Clinical and Translational Science Center.

Massachusetts General Hospital (, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $760 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine. In July 2015, MGH returned into the number one spot on the 2015-16 U.S. News & World Report list of "America's Best Hospitals."

Massachusetts General Hospital

Related Weight Loss Articles:

Cash for weight loss
A new study, published in the journal Social Science and Medicine, has shown that selling rewards programmes to participants entering a weight loss programme is a low cost strategy to increase both the magnitude and duration of weight loss.
Is alternate-day fasting more effective for weight loss?
Alternate day fasting regimens have increased in popularity because some patients find it difficult to adhere to a conventional weight-loss diet.
Bullies and their victims obsessed with weight-loss
School bullies and their victims are more obsessed with weight-loss than anyone else, according to new research by the University of Warwick.
Weight loss actually possible after menopause
Talk to a woman in menopause and you're likely to hear complaints about hot flashes and an inability to lose weight, especially belly fat.
Weight loss reduces psoriasis symptoms
Weight loss has a significant and prolonged positive impact on psoriasis symptoms and quality of life.
Weight loss may help prevent multiple myeloma
Carrying extra weight increases a person's risk that a benign blood disorder will develop into multiple myeloma, a blood cancer.
Gastric bypass is better than other procedures for sustainable weight loss
Gastric bypass surgery is more effective for weight loss and long-term weight maintenance than are other surgical procedures and non-surgical treatment, according to a study led by researchers at Duke Health and the Durham VA Medical Center.
Weight loss surgery associated with increased fracture risk
Severely obese patients undergoing weight loss surgery are more likely to have increased fracture risks both before and after the surgical procedure compared to obese and non-obese people people who don't need surgery, finds a large study published by The BMJ this week.
Online intervention helps sustain weight loss
New research, led by the University of Southampton, has found that an online behavioural counselling tool is effective at helping people lose weight.
Study compares effectiveness of weight-loss drugs
In an analysis that included nearly 30,000 overweight or obese adults, compared with placebo, orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and liraglutide were each associated with achieving at least 5 percent weight loss at 52 weeks, and phentermine-topiramate and liraglutide were associated with the highest odds of achieving at least 5 percent weight loss, according to a study appearing in the June 14 issue of JAMA.

Related Weight Loss Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...